CLINICAL_TRIALS
trial_result
· 2011-03-28
Clinical Trial Update: Vyvanse Adolescent Open-Label Safety and Efficacy Extension Study [Phase 3]
Summary
An open-label extension study for Vyvanse in adolescents evaluated safety and efficacy in a Phase 3 trial.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shire | Conditions: ADHD | Phase 3 | Status: COMPLETED | Results posted: 2011-03-28